Evaluation of serum Resistin in children with chronic renal failure undergoing hemodialysis

Authors

  • Ahmed Ibraheem Hussien M.Sc. of Pediatrics, Pediatrician, the Pediatric Department, Faculty of Medicine, Benha University, Egypt

Keywords:

Resistin; Hemodialysis; Chronic renal failure; Children

Abstract

Introduction: High serum resistin levels are associated with the incidence of chronic kidney disease (CKD). The objectives of this study were to determine the serum concentrations of resistin in children that present with chronic renal failure (CRF) and end stage renal disease (ESRD), in order to examine the impact of hemodialysis (HD) on serum resistin levels, and to determine if a correlation exists between resistin and growth retardation in patients with CRF.

Methods: This case control study was undertaken in the pediatric hemodialysis unit of the Benha and Menoufia University hospitals from April 2014 to March 2015. The case group consisted of 50 patients with CRF aged from 6-18 years (25 of them under HD and 25 of them under conservative treatment) and 30 healthy children who constituted the control group. Urea, creatinine, and serum resistin were measured before and after the HD session for patients with CRF who are already under HD.

Results: A highly significant difference was found between the resistin levels in the two groups with mean level of 20.2 ± 7.58 ng/ml in the patient case group as compared to 4.9 ± 1.72 ng/ml in the control group. This highly significant difference found in the resistin level differed according to the Chronic Kidney Disease (CKD) stage of progression as patients on regular HD had resistin levels with a mean of 24.6 ± 7.28 ng/ml while the CKD patients under conservative treatment have resistin level mean of 15.6 ± 4.72 ng/ml. there was a highly significant difference in resistin levels before HD (mean = 24.6 ± 7.28) and after hemodialysis (mean = 14.7 ± 5.2). 

Conclusion:  Patients with CRF experienced higher than normal resistin levels as compared to the case control group and it was found that patients on HD had more elevated levels of resistin than did those patients who were on conservative treatment. HD treatments were found to be capable of lowering a patient’s resistin levels. A highly significant negative correlation was found between serum resistin levels and the two contributing factors of total body weight and body mass index (BMI) as well as demonstrating a significant negative correlation between serum resistin levels and height percentiles.

 

References

Maggio MC, Montaperto D, Maringhini S, Corrado C, Gucciardino E, Corsello G. Adiponectin, resistin

and leptin in paediatric chronic renal failure: correlation with auxological and endocrine profiles. J

Nephrol. 2014; 27(3): 275-9. doi: 10.1007/s40620-013-0015-2. PMID: 24449263.

McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN, et al. Increased resistin gene and

protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab. 2002; 87(5): 2407. doi:

1210/jcem.87.5.8627. PMID: 11994397.

Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bárány P, Lönnqvist F, et al. Elevated resistin levels

in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not

with insulin resistance. Kidney Int. 2006; 69(3): 596-604. doi: 10.1038/sj.ki.5000089. PMID: 16395259.

Chou HH, Lin CY, Chiou YH, Tain YL, Wang YF, Wang HH, et al. Clinical characteristics and prevalence

of complications of chronic kidney disease in children: the Taiwan Pediatric Renal Collaborative study.

Pediatr Nephrol. 2016; 31(7):1113-20. doi: 10.1007/s00467-016-3325-5. PMID: 26850057.

Naseri M, Mottaghi Moghadam Shahri H, Horri M, Esmaeeli M, Ghaneh Sherbaf F, Jahanshahi S, et al.

Absolute and Relative Carnitine Deficiency in Patients on Hemodialysis and Peritoneal Dialysis. Iran J

Kidney Dis. 2016; 10(1): 36-43. PMID: 26837680.

Pruthi R, Casula A, Inward C, Roderick P, Sinha MD, British Association for Paediatric Nephrology. Early

Requirement for RRT in Children at Presentation in the United Kingdom: Association with Transplantation

and Survival. Clin J Am SocNephrol. 2016; 11(5): 745-802. doi: 10.2215/CJN.08190815. PMID:

Nüsken KD, Kratzsch J, Wienholz V, Stöhr W, Rascher W, Dötsch J. Circulating resistin concentrations in

children depend on renal function. Nephrol Dial Transplant. 2006; 21(1): 107-12. doi: 10.1093/ndt/gfi084.

PMID: 16144855.

Nehus E, Furth S, Warady B, Mitsnefes M. Correlates of Resistin in Children with Chronic Kidney

Disease: The Chronic Kidney Disease in Children Cohort. J Pediatr. 2012; 161(2): 276-80. doi:

1016/j.jpeds.2012.01.055. PMID: 22421264, PMCID: PMC3553545.

Malyszko J, Malyszko JS, Kozminski P, Pawlak K, Mysliwiec M. Elevated resistin is related to

inflammation and residual renal function in haemodialysed patients. Nephrology (Carlton). 2007; 12(3):

-53. doi: 10.1111/j.1440-1797.2007.00782.x. PMID: 17498119.

Díez JJ, Iglesias P, Fernández-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, et al. Serum

concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in

patients with end-stage renal disease. Clin Endocrinol (Oxf). 2005; 62(2): 242-9. doi: 10.1111/j.1365- 2265.2005.02207.x. PMID: 15670203.

Yannakoulia M, Yiannakouris N, Blüher S, Matalas AL, Klimis-Zacas D, Mantzoros CS. Body fat mass

and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin,

and resistin concentrations in healthy humans. J Clin Endocrinol Metab. 2003; 88(4): 1730-6. doi:

1210/jc.2002-021604. PMID: 12679465.

Youn BS, Yu KY, Park HJ, Lee NS, Min SS, Youn MY, et al. Plasma resistin concentrations measured by

enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in

individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004; 89(1): 150-6. doi:

1210/jc.2003-031121. PMID: 14715842.

Briffa JF, McAinch AJ, Poronnik P, Hryciw DH. Adipokines as a link between obesity and chronic kidney

disease. Am J Physiol Renal Physiol. 2013; 305(12): 1629‑36. doi: 10.1152/ajprenal.00263.2013. PMID:

Dan S, Aditya P, Banerjee P, Bal C, Roy H, Banerjee I. Effect of chronic kidney disease on serum resistin

level. Niger J Clin Pract. 2014; 17(6): 735-8. doi: 10.4103/1119-3077.144387. PMID: 25385911.

Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin

levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003; 149(4): 331- 5. doi: 10.1530/eje.0.1490331. PMID: 14514348. 16) Zein MY, Abdel-Salam M, Abdel-Aziz I, Fathy Mohamed N. Serum Resistin Level and

Polymorphonuclear Leukocytes Dysfunctions in Children on Regular Hemodialysis. International Journal

of Clinical Medicine. 2015; 6(6): 423-30. doi: 10.4236/ijcm.2015.66055.

Hoffmann MM, Pilz S, Weihrauch G, Seelhorst U, Wellnitz B, Winkelmann BR, et al. Effect of the resistin

-420C > G polymorphism on cardiovascular disease and mortality. Clin Endocrinol (Oxf). 2008; 69(2):

-5. doi: 10.1111/j.1365-2265.2007.03163.x. PMID: 18167137.

Kielstein JT, Becker B, Graf S, Brabant G, Haller H, Fliser D. Increased resistin blood levels are not

associated with insulin resistance in patients with renal disease. Am J Kidney Dis. 2003; 42(1): 62-6. doi:

1016/S0272-6386(03)00409-8.

Filippidis G, Liakopoulos V, Mertens PR, Kiropoulos T, Stakias N, Verikouki C, et al. Resistin serum

levels are increased but not correlated with insulin resistance in chronic hemodialysis patients. Blood Purif.

; 23(6): 421-8. doi: 10.1159/000088017. PMID: 16141714.

Carracedo J, Ramírez R, Madueño JA, Soriano S, Rodríguez-Benot A, Rodríguez M, et al. Cell apoptosis

and hemodialysis-induced inflammation. Kidney Int Suppl. 2002; 80: 89-93. doi: 10.1046/j.1523- 1755.61.s80.17.x. PMID: 11982820.

Horl WH. Hemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules. J Am Soc

Nephrol. 2002; 13: 62-71. PMID: 11792764.

Bowry SK, Gatti E, Vienken J. Contribution of polysulfone membranes to the success of convective

dialysis therapies. Contrib Nephrol. 2011; 173: 110-8. doi: 10.1159/000328960. PMID: 21865783.

Published

2022-03-07

Issue

Section

Articles